Sukla P, Shrivastava SR, Shrivastava PS, Rao NL. Assessment of the cardiac autonomic neuropathy among the known diabetics and age-matched controls using noninvasive cardiovascular reflex tests in a south-indian population: a case-control study. Avicenna J Med. 2016;6(3):81–5.

Article  PubMed  PubMed Central  Google Scholar 

Franceschi R, Mozzillo E, Di Candia F, Rosanio FM, Leonardi L, Liguori A, et al. A systematic review of the prevalence, risk factors and screening tools for autonomic and diabetic peripheral neuropathy in children, adolescents and young adults with type 1 Diabetes. Acta Diabetol. 2022;59(3):293–308.

Article  PubMed  Google Scholar 

da Rocha RB, Silva CS, Cardoso VS. Self-care in adults with type 2 Diabetes Mellitus: a systematic review. Curr Diabetes Rev. 2020;16(6):598–607.

Article  PubMed  Google Scholar 

Mansoori A, Sahranavard T, Hosseini ZS, Soflaei SS, Emrani N, Nazar E, et al. Prediction of type 2 Diabetes Mellitus using hematological factors based on machine learning approaches: a cohort study analysis. Sci Rep. 2023;13(1):663.

Article  PubMed  PubMed Central  Google Scholar 

Nanayakkara N, Curtis AJ, Heritier S, Gadowski AM, Pavkov ME, Kenealy T, et al. Impact of age at type 2 Diabetes Mellitus diagnosis on mortality and vascular Complications: systematic review and meta-analyses. Diabetologia. 2021;64(2):275–87.

Article  PubMed  Google Scholar 

Freeman R. Diabetic autonomic neuropathy. Handb Clin Neurol. 2014;126:63–79.

Article  PubMed  Google Scholar 

Braffett BH, Gubitosi-Klug RA, Albers JW, Feldman EL, Martin CL, White NH, et al. Risk factors for Diabetic Peripheral Neuropathy and Cardiovascular Autonomic Neuropathy in the Diabetes Control and Complications Trial/Epidemiology of Diabetes Interventions and Complications (DCCT/EDIC) study. Diabetes. 2020;69(5):1000–10.

Article  PubMed  PubMed Central  Google Scholar 

Tandon R, Bajpai HS, Agrawal JK. Non-coronary cardiac complications in diabetes mellitus. J Assoc Physicians India. 1985;33(11):747.

PubMed  Google Scholar 

Faselis C, Katsimardou A, Imprialos K, Deligkaris P, Kallistratos M, Dimitriadis K. Microvascular Complications of type 2 Diabetes Mellitus. Curr Vasc Pharmacol. 2020;18(2):117–24.

Article  PubMed  Google Scholar 

Hejazi K, Mohammad Rahimi GR, Rosenkranz SK. Effects of Exercise training on inflammatory and cardiometabolic risk biomarkers in patients with type 2 Diabetes Mellitus: a systematic review and Meta-analysis of Randomized controlled trials. Biol Res Nurs. 2023;25(2):250–66.

Article  PubMed  Google Scholar 

She N, Liu N, Ren X, Liu H. Association between Omentin and obstructive sleep apnea: a meta-analysis. Clin Respir J. 2023;17(3):139–47.

Article  PubMed  PubMed Central  Google Scholar 

Watanabe T, Watanabe-Kominato K, Takahashi Y, Kojima M, Watanabe R. Adipose tissue-derived Omentin-1 function and regulation. Compr Physiol. 2017;7(3):765–81.

Article  PubMed  Google Scholar 

Brunetti L, Leone S, Orlando G, Ferrante C, Recinella L, Chiavaroli A, et al. Hypotensive effects of omentin-1 related to increased adiponectin and decreased interleukin-6 in intra-thoracic pericardial adipose tissue. Pharmacol Rep. 2014;66(6):991–5.

Article  PubMed  Google Scholar 

de Souza Batista CM, Yang RZ, Lee MJ, Glynn NM, Yu DZ, Pray J, et al. Omentin plasma levels and gene expression are decreased in obesity. Diabetes. 2007;56(6):1655–61.

Article  PubMed  Google Scholar 

Moreno-Navarrete JM, Catalán V, Ortega F, Gómez-Ambrosi J, Ricart W, Frühbeck G, et al. Circulating omentin concentration increases after weight loss. Nutr Metabolism. 2010;7: 27.

Article  Google Scholar 

Shibata R, Ouchi N, Takahashi R, Terakura Y, Ohashi K, Ikeda N, et al. Omentin as a novel biomarker of metabolic risk factors. Diabetol Metab Syndr. 2012;4(1): 37.

Article  PubMed  PubMed Central  Google Scholar 

Jung CH, Jung SH, Kim BY, Kim CH, Kang SK, Mok JO. Association of serum omentin levels with cardiac autonomic neuropathy in patients with type 2 Diabetes Mellitus: a hospital-based study. Cardiovasc Diabetol. 2015;14:140.

Article  PubMed  PubMed Central  Google Scholar 

Higgins JP, Thompson SG, Deeks JJ, Altman DG. Measuring inconsistency in meta-analyses. BMJ. 2003;327(7414):557–60.

Article  PubMed  PubMed Central  Google Scholar 

DerSimonian R, Laird N. Meta-analysis in clinical trials revisited. Contemp Clin Trials. 2015;45:139–45.

Article  PubMed  PubMed Central  Google Scholar 

Higgins JP, Thompson SG. Quantifying heterogeneity in a meta-analysis. Stat Med. 2002;21(11):1539–58.

Article  PubMed  Google Scholar 

Pan X, Wang Z, Wu X, Wen SW, Liu A. Salivary cortisol in post-traumatic stress disorder: a systematic review and meta-analysis. BMC Psychiatry. 2018;18:1–10.

Article  PubMed  PubMed Central  Google Scholar 

Mustafa HI, Zbaar SA, Salman MS. Study the role serum Omentin-1 in occurrence and development of Diabetic Retinopathy. Prof(Dr. RK Sharma. 2020;20(4):41915.

Google Scholar 

Senthilkumar GP, Anithalekshmi MS, Yasir M, Parameswaran S, Packirisamy RM, Bobby Z. Role of omentin 1 and IL-6 in type 2 Diabetes Mellitus patients with diabetic Nephropathy. Diabetes Metab Syndr. 2018;12(1):23–6.

Article  PubMed  Google Scholar 

Herder C, Bongaerts BWC, Ouwens DM, Rathmann W, Heier M, Carstensen-Kirberg M, et al. Low serum omentin levels in the elderly population with type 2 Diabetes and polyneuropathy. Diabet Med. 2015;32(11):1479–83.

Article  PubMed  Google Scholar 

Wan W, Li Q, Zhang F, Zheng G, Lv Y, Wan G, et al. Serum and vitreous concentrations of Omentin-1 in Diabetic Retinopathy. Dis Markers. 2015;2015:754312.

Article  PubMed  PubMed Central  Google Scholar 

Devi RV, Subramaniam V, Adole PS, Senthilkumar GP, Mehalingam V. Cardiovascular autonomic neuropathy in patients with type 2 Diabetes Mellitus and its association with serum omentin and leptin. J Family Med Prim Care. 2020;9(6):2926–30.

Article  PubMed  PubMed Central  Google Scholar 

Eimal Latif AH, Anwar S, Gautham KS, Kadurei F, Ojo RO, Hafizyar F et al. Association of plasma omentin-1 levels with Diabetes and its Complications. Cureus. 2021;13(9):e18203.

Zorlu M, Kiskac M, Güler EM, Gültepe I, Yavuz E, Çelik K, et al. Serum obestatin and omentin levels in patients with diabetic Nephropathy. Niger J Clin Pract. 2017;20(2):182–7.

Article  PubMed  Google Scholar 

Abdelraouf Korany M, Sonbol A, Mohamed Elgouhary S. Omentin-1 and diabetic retinopathy in type 2 diabetic patients. Alexandria J Med. 2018;54(4):323–6.

Article  Google Scholar 

Omae T, Nagaoka T, Yoshida A. Effect of circulating omentin-1 on the retinal circulation in patients with type 2 Diabetes Mellitus. Investig Ophthalmol Vis Sci. 2017;58(12):5086–92.

Article  Google Scholar 

Scanlon PH, Sallam A, Van Wijngaarden P. A practical manual of diabetic retinopathy management. John Wiley & Sons; 2017.

Robberecht H, Hermans N. Biomarkers of metabolic syndrome: biochemical background and clinical significance. Metab Syndr Relat Disord. 2016;14(2):47–93.

Article  PubMed  Google Scholar 

Al-Karawi IN, Al-Fahdawi SSM. Assessment of Omentin-1 as a predictor and Renoprotective for type 2 Diabetic Nephropathy. Iraqi J Community Med. 2017;30(1).

Sun Y-M, Su Y, Li J, Wang L-F. Recent advances in understanding the biochemical and molecular mechanism of diabetic Nephropathy. Biochem Biophys Res Commun. 2013;433(4):359–61.

Article  PubMed  Google Scholar 

Abid O, Sun Q, Sugimoto K, Mercan D, Vincent J-L. Predictive value of microalbuminuria in medical ICU patients: results of a pilot study. Chest. 2001;120(6):1984–8.

Article  PubMed  Google Scholar 

Kataoka Y, Shibata R, Ohashi K, Kambara T, Enomoto T, Uemura Y, et al. Omentin prevents myocardial ischemic injury through AMP-activated protein kinase-and akt-dependent mechanisms. J Am Coll Cardiol. 2014;63(24):2722–33.

Article  PubMed  Google Scholar 

Akiyama Y, Oshima K, Kuhara T, Shin K, Abe F, Iwatsuki K, et al. A lactoferrin-receptor, intelectin 1, affects uptake, sub-cellular localization and release of immunochemically detectable lactoferrin by intestinal epithelial Caco-2 cells. J Biochem. 2013;154(5):437–48.

Article  PubMed  Google Scholar 

Moreno-Navarrete J, Ortega F, Bassols J, Ricart W, Fernández-Real J. Decreased circulating lactoferrin in insulin resistance and altered glucose tolerance as a possible marker of neutrophil dysfunction in type 2 Diabetes. J Clin Endocrinol Metabolism. 2009;94(10):4036–44.

Article  Google Scholar 

Yamawaki H, Kuramoto J, Kameshima S, Usui T, Okada M, Hara Y. Omentin, a novel adipocytokine inhibits TNF-induced vascular inflammation in human endothelial cells. Biochem Biophys Res Commun. 2011;408(2):339–43.

Article  PubMed  Google Scholar 

Kellogg AP, Wiggin TD, Larkin DD, Hayes JM, Stevens MJ, Pop-Busui R. Protective effects of cyclooxygenase-2 gene inactivation against peripheral nerve dysfunction and intraepidermal nerve fiber loss in experimental Diabetes. Diabetes. 2007;56(12):2997–3005.

Article  PubMed  Google Scholar 

Moreno-Navarrete JM, Catalán V, Ortega F, Gómez-Ambrosi J, Ricart W, Frühbeck G, et al. Circulating omentin concentration increases after weight loss. Nutr Metabolism. 2010;7:1–6.

Article  Google Scholar 

Gürsoy G, Kırnap N, Eşbah O, Acar Y, Demirbaş B, Akçayöz S, et al. The relationship between plasma omentin-1 levels and insulin resistance in newly diagnosed type 2 diabetıc women. Clin Rev Opin. 2010;2(4):49–54.

Google Scholar 

Forbes JM, Cooper ME. Mechanisms of diabetic Complications. Physiol Rev. 2013;93(1):137–88.

Article  PubMed  Google Scholar